Clinical trials
Recruiting Vulvar Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zhejiang Cancer Hospital | 2 |
| HRYZ Biotech Co. | 1 |
| Shanghai Bovax Biotechnology Co., Ltd. | 1 |
| Sichuan Enray Pharmaceutical Sciences Company | 1 |
| The Affiliated Hospital of Qingdao University | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vulvar Neoplasms | 7 |
| Uterine Cervical Neoplasms | 6 |
| Vaginal Neoplasms | 6 |
| Anus Neoplasms | 2 |
| Penile Neoplasms | 2 |
| Colorectal Neoplasms | 1 |
| Condylomata Acuminata | 1 |
| Endometrial Neoplasms | 1 |
| Genital Neoplasms, Female | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.